ZEAL
Zealand Pharma A/S.
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| Actual EPS |
|---|
| Consensus EPS |
| Estimated EPS |
| Number of Estimates |
| EPS Surprise |
Stats
Summary
Market Cap: 1.5 Billion
Primary Exchange: NASDAQ/NGS (GLOBAL SELECT MARKET)
Website: https://www.zealandpharma.com/
Shares Outstanding: 39.8 Million
Float: 0
Dividend: 0.0 (0.0%)
Beta: 0.0
Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Ethical Flags
Longest drawdown: 413 trading days
From: 2017-09-06 To: 2019-04-26
Lowest Point:
Zealand up 2% premarket on positive dasiglucagon data
via: SeekingAlpha at 2019-06-11 05:16:45:000
Thinly traded Zealand Pharma A/S (NASDAQ: ZEAL ) is up 2% premarket on light volume in response to additional data from a Phase 3 clinical trial evaluating a single dose of dasiglucagon as a rescue treatment in diabetic patients with severe hypoglycemia (low blood sugar). The r… read more...
Zealand up 2% premarket on positive dasiglucagon data
via: SeekingAlpha at 2019-06-11 05:16:45:000
Thinly traded Zealand Pharma A/S (NASDAQ: ZEAL ) is up 2% premarket on light volume in response to additional data from a Phase 3 clinical trial evaluating a single dose of dasiglucagon as a rescue treatment in diabetic patients with severe hypoglycemia (low blood sugar). The r… read more...
Zealand up 2% premarket on positive dasiglucagon data
via: SeekingAlpha at 2019-06-11 05:16:45:000
Thinly traded Zealand Pharma A/S (NASDAQ: ZEAL ) is up 2% premarket on light volume in response to additional data from a Phase 3 clinical trial evaluating a single dose of dasiglucagon as a rescue treatment in diabetic patients with severe hypoglycemia (low blood sugar). The r… read more...
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|